Interim Report 2026
Filed with HKEX · Stock code 9996 · · 103 pages · English
Earlier from Peijia Medical
- Peijia Medical Announces 2026 Interim Results, Achieving First-Ever Profit Before Tax on Strong TAVR Growth
- Peijia Medical Announces 2025 Annual Results
- DCwire® Micro Guidewire Receives FDA 510(k) Clearance, Marking a Key Milestone in Peijia Medical's Global Expansion
- Peijia Medical Submits EU MDR CE Mark Registration Application for GeminiOne® TEER System
- Peijia Medical Receives NMPA Approval for TaurusTrio Transcatheter Aortic Valve System, Pioneering Treatment for Aortic Regurgitation in China
Later from Peijia Medical
- Notification Letter and Reply Form to Registered Shareholders - Reminder Letter regarding the Arrangement of Electronic Dissemination of Corporate Communications
- Voluntary announcement
- Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2026
Follow Peijia Medical into a list and get an email when it puts out news.
Follow Peijia Medical